Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 714075, 10 pages
http://dx.doi.org/10.1155/2013/714075
Research Article

The Inhibitory Effect of Haloxylon salicornicum on Contraction of the Mouse Uterus

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK

Received 19 March 2013; Accepted 19 August 2013

Academic Editor: Roman Huber

Copyright © 2013 Nabila H. Saleem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye, “Endocrine and paracrine regulation of birth at term and preterm,” Endocrine Reviews, vol. 21, no. 5, pp. 514–550, 2000. View at Google Scholar · View at Scopus
  2. R. M. Tribe, “Regulation of human myometrial contractility during pregnancy and labour: are calcium homeostatic pathways important?” Experimental Physiology, vol. 86, no. 2, pp. 247–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Wray, K. Jones, S. Kupittayanant et al., “Calcium signaling and uterine contractility,” Journal of the Society for Gynecologic Investigation, vol. 10, no. 5, pp. 252–264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Blencowe, S. Cousens, M. Z. Oestergaard et al., “National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications,” The Lancet, vol. 379, no. 9832, pp. 2162–2172, 2012. View at Google Scholar
  5. M. V. Kinney, K. J. Kerber, R. E. Black et al., “Sub-Saharan Africa's mothers, newborns, and children: where and why do they die?” PLoS Medicine, vol. 7, no. 6, Article ID e1000294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Ronsmans and W. J. Graham, “Maternal mortality: who, when, where, and why,” The Lancet, vol. 368, no. 9542, pp. 1189–1200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Abramovici, J. Cantu, and S. M. Jenkins, “Tocolytic therapy for acute preterm labor,” Obstetrics and Gynecology Clinics of North America, vol. 39, no. 1, pp. 77–87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Y. R. Kam and R. F. Lamont, “Developments in the pharmacotherapeutic management of spontaneous preterm labor,” Expert Opinion on Pharmacotherapy, vol. 9, no. 7, pp. 1153–1168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. Haas, D. M. Caldwell, P. Kirkpatrick, J. J. McIntosh, and N. J. Welton, “Tocolytic therapy for preterm delivery: systematic review and network meta-analysis,” British Medical Journal, vol. 345, article e6226, 2012. View at Google Scholar
  10. C. W. Gruber and M. O'Brien, “Uterotonic plants and their bioactive constituents,” Planta Medica, vol. 77, no. 3, pp. 207–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. Proctor and P. A. Murphy, “Herbal and dietary therapies for primary and secondary dysmenorrhoea,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD002124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Saleem, An ethno-pharmacological study of Egyptian Bedouin women's knowledge of medicinal plants [Ph.D. thesis], University of Strathclyde, Glasgow, UK, 2012.
  13. L. Boulos, Flora of Egypt, vol. 1, Al-Hadra, Cairo, Egypt, 1999.
  14. M. A. Ashraf, M. Karamat, K. Shahnaz, W. Abdul, and Y. Ismail, “Study of chemical and mineral constituents of Haloxylon salicornicum collected from Cholistan Desert, Bahawalpur, Pakistan,” Wlfenia Journal, vol. 19, no. 10, pp. 306–327, 2012. View at Google Scholar
  15. V. Tackholm, Students' Flora of Egypt, Cairo University Press, Cairo, Egypt, 2nd edition, 1974.
  16. M. A. Ajabnoor, M. A. Al-Yahya, M. Tariq, and A. A. Jayyab, “Antidiabetic activity of Hammada salicornica,” Fitoterapia, vol. 55, no. 2, pp. 107–109, 1984. View at Google Scholar · View at Scopus
  17. A. M. El-Shazly, G. Dora, and M. Wink, “Alkaloids of Haloxylon salicornicum (Moq.) Bunge ex Boiss. (Chenopodiaceae),” Pharmazie, vol. 60, no. 12, pp. 949–952, 2005. View at Google Scholar · View at Scopus
  18. S. Gibbons, B. J. Denny, S. Ali-Amine et al., “NMR spectroscopy, X-ray crystallographic, and molecular modeling studies on a new pyranone from Haloxylon salicornicum,” Journal of Natural Products, vol. 63, no. 6, pp. 839–840, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yokoo, H. Kohda, A. Kusumoto et al., “Isolation from beer and structural determination of a potent stimulant of gastrin release,” Alcohol and Alcoholism, vol. 34, no. 2, pp. 161–168, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. A. N. Rasheed, F. U. Afifi, M. Shaedah, and M. O. Taha, “Investigation of the active constituents of Portulaca oleraceae L. (Portulacaceae) growing in Jordan,” Pakistan Journal of Pharmaceutical Sciences, vol. 17, no. 1, pp. 37–45, 2004. View at Google Scholar
  21. W. A. Mahon, D. W. Reid, and R. A. Day, “The in vivo effects of beta adrenergic stimulation and blockade on the human uterus at term,” The Journal of Pharmacology and Experimental Therapeutics, vol. 156, no. 1, pp. 178–185, 1967. View at Google Scholar · View at Scopus
  22. G. Emilien and J.-M. Maloteaux, “Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists,” European Journal of Clinical Pharmacology, vol. 53, no. 6, pp. 389–404, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. J. N. Pennefather and P. Molenaar, “β2-adrenoreceptor binding sites in circular and longitudinal myometrial layers of the virgin guinea-pig: the influence of ovarian steroids,” Journal of Autonomic Pharmacology, vol. 6, no. 3, pp. 207–213, 1986. View at Google Scholar · View at Scopus
  24. M. Breuiller, B. Rouot, M.-J. Leroy, P. Blot, L. Kaplan, and F. Ferré, “Adrenergic receptors in inner and outer layers of human myometrium near term: Characterization of beta-adrenergic receptor sites by 125I-iodocyanopindolol binding,” Gynecologic and Obstetric Investigation, vol. 24, no. 1, pp. 28–37, 1987. View at Google Scholar · View at Scopus
  25. J. P. Maltier and C. Legrand, “Characterization of β-adrenoceptors in myometrium of preparturient rats,” Fundamental and Clinical Pharmacology, vol. 2, no. 5, pp. 369–383, 1988. View at Google Scholar · View at Scopus
  26. R. C. Bhalla, R. M. Sanborn, and S. G. Korenman, “Hormonal interactions in the uterus: inhibition of isoproterenol-induced accumulation of adenosine 3′:5′-cyclic monophosphate by oxytocin and prostaglandins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 69, no. 12, pp. 3761–3764, 1972. View at Google Scholar · View at Scopus
  27. W. Giles and A. Bisits, “The present and future of tocolysis,” Best Practice & Research, vol. 21, no. 5, pp. 857–868, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Gsell, T. Eschenhagen, G. Kaspareit et al., “Apparent up-regulation of stimulatory G-protein α subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression,” The FASEB Journal, vol. 14, no. 1, pp. 17–26, 2000. View at Google Scholar · View at Scopus
  29. M.-H. Litime, G. Pointis, M. Breuiller, D. Cabrol, and F. Ferre, “Disappearance of β-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 1, pp. 1–6, 1989. View at Google Scholar · View at Scopus
  30. M. A. Cruz, W. H. Sepúlveda, and M. I. Rudolph, “Changes in the response to adrenergic drugs on mouse uterine contractions during pregnancy,” Life Sciences, vol. 46, no. 2, pp. 99–104, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Berg, R. G. G. Andersson, and G. Rydén, “β-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after β-mimetic treatment,” American Journal of Obstetrics and Gynecology, vol. 151, no. 3, pp. 392–396, 1985. View at Google Scholar · View at Scopus
  32. L. B. Fernandes, P. J. Henry, and R. G. Goldie, “β-adrenoceptor agonists,” in Handbook of Experimental Pharmacology, C. P. Page and P. J. Barnes, Eds., vol. 161, pp. 4–35, 2004. View at Google Scholar
  33. I. Stewart, W. F. Newhall, and G. J. Edwards, “The isolation and identification of l-synephrine in the leaves and fruit of citrus,” The Journal of Biological Chemistry, vol. 239, no. 3, pp. 930–932, 1964. View at Google Scholar
  34. G. E. Bartley, A. P. Breksa III, and B. K. Ishida, “PCR amplification and cloning of tyrosine decarboxylase involved in synephrine biosynthesis in Citrus,” New Biotechnology, vol. 27, no. 4, pp. 308–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Mercader, E. Wanecq, J. Chen, and C. Carpéné, “Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium,” Journal of Physiology and Biochemistry, vol. 67, no. 3, pp. 443–452, 2011. View at Google Scholar · View at Scopus
  36. S. Haaz, K. R. Fontaine, G. Cutter, N. Limdi, S. Perumean-Chaney, and D. B. Allison, “Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update,” Obesity Reviews, vol. 7, no. 1, pp. 79–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. C. M. Brown, J. C. McGrath, J. M. Midgley et al., “Activities of octopamine and synephrine stereoisomers on α-adrenoceptors,” British Journal of Pharmacology, vol. 93, no. 2, pp. 417–429, 1988. View at Google Scholar · View at Scopus
  38. T. A. Wheaton and I. Stewart, “The distribution of tyramine, n-methyltyramine, hordenine, octopamine, and synephrine in higher plants,” Lloydia, vol. 33, no. 2, pp. 244–254, 1970. View at Google Scholar · View at Scopus
  39. K. H. Michel, F. Sandberg, F. Haglid, and T. Norin, “Alkaloids of Haloxylon salicornicum (Moq.-Tand.) Boiss,” Acta Pharmaceutica Suecica, vol. 4, no. 2, pp. 97–116, 1967. View at Google Scholar · View at Scopus
  40. K. H. Michel and F. Sandberg, “Occurrence of tyramine and n-methyltyramine in Haloxylon salicornicum (Moq.-Tand.) Boiss,” Acta Pharmaceutica Suecica, vol. 5, no. 2, pp. 67–70, 1968. View at Google Scholar · View at Scopus
  41. L. C. Sander, K. Putzbach, B. C. Nelson et al., “Certification of standard reference materials containing bitter orange,” Analytical and Bioanalytical Chemistry, vol. 391, no. 6, pp. 2023–2034, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. U. von Euler and F. Lishajko, “Improved technique for the fluorimetric estimation of catecholamines,” Acta physiologica Scandinavica, vol. 51, no. 4, pp. 348–355, 1961. View at Google Scholar · View at Scopus
  43. C. S. Evans, E. A. Bell, and E. S. Johnson, “N-methyltyramine, a biologically active amine in acacia seeds,” Phytochemistry, vol. 18, no. 12, pp. 2022–2023, 1979. View at Google Scholar · View at Scopus
  44. C. Urquhart, R. Currell, F. Harlow, and E. Callow, “Home uterine monitoring for detecting preterm labour,” Cochrane Database of Systematic Reviews, no. 5, Article ID CD006172, 2012. View at Publisher · View at Google Scholar · View at Scopus